Self-Propelled Nanoreactors for Enhanced Cascade Catalytic Cancer Therapy through NIR-II Fluorescence Imaging-Guided Readministration
ACS Nano · 03.02.2026 · 20 (4) · 3696-3709
DOI: 10.1021/acsnano.5c17672 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 16.01.2026. Verfasst von Mengzhen Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chronic Disease, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China. Hauptthemen laut MEDLINE: Optical Imaging, Nanoparticles, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Natural Science Foundation of Qingdao Municipality, Taishan Scholar Project of Shandong Province, Qingdao University.
Abstract (Originalsprache)
The limited penetration depth of nanoreactors within tumors and the inaccurate selection of the optimal timing for readministration significantly restrict the efficacy of cascade catalytic therapy. Therefore, the development of nanoreactors with strong penetration capabilities into tumor tissues and precise readministration recognition systems is of great importance for improving the therapeutic outcomes of cancer treatment. Herein, a self-propelled nanoreactor (designated as DSFGC) is developed. Composed of near-infrared-II fluorescence nanoparticles, a peroxidase (POD)-like nanozyme, and asymmetric functionalized modifications of catalase (CAT) and glucose oxidase (GOx), this nanoreactor is designed to enhance tissue penetration capabilities and identify the optimal readministration timing, thus promoting cascade catalytic therapy efficacy. In tumors, the overexpressed H2O2 is catalytically decomposed into O2 by CAT. This process facilitates the penetration of nanoreactors into deep tumor tissues and acts as an oxygen source to enhance the ability of GOx to catalytically consume glucose, yielding gluconic acid and supplying H2O2. The generated gluconic acid can boost the catalytic activity of the POD-like nanozyme and increase the production of •OH. Moreover, by leveraging the information obtained from near-infrared-II fluorescence imaging to determine the optimal time for readministration, the cascading catalytic therapeutic effects of starvation therapy and chemodynamic therapy can be augmented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chronic Disease, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China.
ORCID-Profile: Qinrui Fu
Förderung
- Natural Science Foundation of Qingdao Municipality
- Taishan Scholar Project of Shandong Province
- Qingdao University
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, M., Jiang, Z., Zhang, H., & Fu, Q. (2026). Self-Propelled Nanoreactors for Enhanced Cascade Catalytic Cancer Therapy through NIR-II Fluorescence Imaging-Guided Readministration. ACS Nano, 20(4), 3696-3709. https://doi.org/10.1021/acsnano.5c17672
Vancouver
Wang M, Jiang Z, Zhang H, Fu Q. Self-Propelled Nanoreactors for Enhanced Cascade Catalytic Cancer Therapy through NIR-II Fluorescence Imaging-Guided Readministration. ACS Nano. 2026;20(4):3696-3709. doi:10.1021/acsnano.5c17672
BibTeX
@article{Wang2026,
author = {Wang, Mengzhen and Jiang, Zeyu and Zhang, Heyi and Fu, Qinrui},
title = {Self-Propelled Nanoreactors for Enhanced Cascade Catalytic Cancer Therapy through NIR-II Fluorescence Imaging-Guided Readministration},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {4},
pages = {3696--3709},
doi = {10.1021/acsnano.5c17672}
}
EUVIMED